Victor Ching
Urology · Upland, CANPI 1356334437
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $665,444 of the $808,983 with a category attached, or 82.3%. Medtronic accounts for 99.8% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $532,685 and has fallen 99.6% since, to $2,049 in 2025. Among urology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $8698.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$807K
- Astellas Pharma US Inc$366
- AbbVie$328
- Procept Biorobotics Corporation$195
- Boston Scientific$162
- Pfizer$143
- plus $752 from 18 others
What the payments were for
- Royalty or licence$665,44482%
- Food & beverage$1,9800%
- Education$50%
- Other$141,55417%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(4 entities) | 14 | $807,037 |
| Astellas Pharma US Inc | 16 | $366 |
| AbbVie(2 entities) | 27 | $328 |
| Procept Biorobotics Corporation | 2 | $195 |
| Boston Scientific | 3 | $162 |
| Pfizer | 6 | $143 |
| Urogen Pharma, Inc. | 2 | $131 |
| Olympus America Inc. | 1 | $128 |
| Telix Pharmaceuticals | 1 | $84 |
| Endo Pharmaceuticals Inc. | 5 | $83 |
| Axonics, Inc. | 3 | $78 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $37 |
| Bayer | 1 | $22 |
| Antares Pharma, Inc. | 1 | $22 |
| Blue Earth Diagnostics | 1 | $21 |
| Pelvital USA, Inc. | 1 | $21 |
| Travere Therapeutics, Inc. | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| Cook Medical LLC | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Coloplast | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| AstraZeneca | 1 | $12 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InPen$555,174
- VenaSeal$34,267
- INPEN SMART INSULIN DELIVERY SYSTEM$23,731
- AquaBeam Robotic System$144
- Soltive$128
- Bovie$128
- JELMYTO$126
- GENERAL ONCOLOGY$124
How this compares
$808,983 in reported general payments places this provider in the 95th percentile of 1,324 urology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 11 | $77 |
Paid to pharmacies, not to this prescriber.
Other urology in Upland
- Stephen FreedlandWest Hollywood$1.9M
- Arie BelldegrunLos Angeles$1.8M
- Mihir DesaiLos Angeles$1.5M
- Steven WilsonIndio$1.1M
- Stuart HoldenLos Angeles$1.1M
- Elward CrawfordSan Diego$849K
- Edward UchioOrange$849K
- Jaime LandmanOrange$657K
- William AronsonLos Angeles$540K
- Ralph ClaymanOrange$523K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.